Therefore, the present study reports that saroglitazar could ameliorate obesity and associated inflammation through involvement of NLRP3 and NF- κB proteins which has not been demonstrated earlier. Here, NLRP3 is linked to obesity due to melanocortin 4 receptor deficiency.